Emulate, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-16. The offering totals $50.0M, of which $28.0M was reported sold. Industry: Biotechnology.
Showing 25 of 41 people.
| Name | Role | Location |
|---|---|---|
| David James Coon | Director | Boston, MA |
| Geraldine A Hamilton | Director | Boston, MA |
| Sharon R Kedar | Director | Boston, MA |
| Daniel R Levner | Director | Boston, MA |
| Shlomo A Melmed | Director | Boston, MA |
| Eric A Moessinger | Director | Seattle, WA |
| Aaron A VanDevender | Director | Boston, MA |
| Franklin R Witney | Director | San Diego, CA |
| David James Coon | Executive Officer | Boston, MA |
| Harminder R Dhaliwal | Executive Officer | Boston, MA |
| Geraldine A Hamilton | Executive Officer | Boston, MA |
| Sandy R Lazzari | Executive Officer | Boston, MA |
| Daniel R Levner | Executive Officer | Boston, MA |
| Monique R Noel | Executive Officer | Boston, MA |
| Martin Madaus | Director | Boston, MA |
| Aaron VanDevender | Director | PALO ALTO, CA |
| Gregory D Williams | Executive Officer | Jefferson City, TN |
| Donald Ingber | Director | Boston, MA |
| Michael Egholm | Director | BRANFORD, CT |
| James Corbett | Director | Salt Lake City, UT |
| James Corbett | Executive Officer | Salt Lake City, UT |
| Eric Moessinger | Director | San Francisco, CA |
| Shlomo Melmed | Director | San Jose, CA |
| Franklin Witney | Director | Boston, MA |
| Sharon Kedar | Director | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-09-07 | D | $57.5M | $57.5M |
| 2020-03-23 | D | $20.0M | $19.3M |
| 2018-06-21 | D | $36.0M | $36.0M |
| 2017-11-09 | D | — | $746K |
| 2016-03-28 | D | $45.0M | $28.8M |
| 2014-07-28 | D | $12.0M | $12.0M |